TrialAlzheimer's research & therapy2026

Uncovering lipid biomarkers linked to methylphenidate efficacy in treating apathy in Alzheimer's disease: insights from the ADMET 2 trial.

Myuri Ruthirakuhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.